Caleres (CAL) AI Stock Analysis

• Market Cap: $484.63M
• Dividend Yield: 1.96%
• Average Volume (3M): 829.03K
• Price to Earnings (P/E): 8.2
• Beta (1Y): 1.04
• Revenue Growth: -5.31%
• EPS Growth: -62.20%
• Country: US
• Employees: 4,800
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Apparel - Footwear & Accessories
• EPS (TTM): 0.35
• Shares Outstanding: 33,842,888
• 10 Day Avg. Volume: 972,896
• 30 Day Avg. Volume: 829,031
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 2.51
• Enterprise Value/Revenue: 0.46
• Enterprise Value/Gross Profit: 1.04
• Enterprise Value/Ebitda: 9.42
• 1Y Price Target: $16.00
• Price Target Upside: 12.12% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 2

• Rating: 63 Neutral
• Price Target: $16.00 ▲(12.12% Upside)

Caleres' overall stock score reflects a challenging financial performance with significant cash flow issues and declining sales. However, the stock's technical indicators show a neutral to slightly positive trend, and its valuation suggests potential undervaluation. The balanced sentiment from the earnings call highlights both strategic achievements and ongoing challenges.

Caleres Business Overview & Revenue Model

Company Description

Caleres, Inc. engages in the retail and wholesale of footwear in the United States, Canada, China, and Guam. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products to women, men, and children. Its retail shoe stores provide brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Converse, Crocs, Puma, Birkenstock, New Balance, Asics, New Balance, Under Armour, Bearpaw, Timberland, Sperry, and Dr. Martens, as well as company-owned and licensed brands, such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Zodiac, Circus by Sam Edelman, Franco Sarto, and Ryka. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, allenedmonds.com, drschollsshoes.com, lifestride.com, francosarto.com, ryka.com, bzees.com, and zodiacshoes.com, as well as Vince.com, blowfishshoes.com, and veronicabeard.com websites. In addition, it designs, sources, manufactures, and markets footwear to retail stores, such as national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalogs. Further, the company wholesales men's apparel, leather goods, and accessories under the Allen Edmonds brand; footwear for women under LifeStride brand; Italian footwear Franco Sarto brand; athletic footwear for women under the Rykä brand; women's shoe collection under the Vince brand; and women's footwear under the Bzees brand; other footwear under Zodiac brand; and women's footwear collection under Veronica Beard brand, as well as Via Spiga brand. It operates approximately 980 retail stores. The company was formerly known as Brown Shoe Company, Inc. Caleres, Inc. was founded in 1878 and is headquartered in St. Louis, Missouri.

How the Company Makes Money

Caleres generates revenue primarily through the sale of footwear across its retail and wholesale channels. The company's key revenue streams include direct sales from its Famous Footwear stores and e-commerce platform, as well as wholesale partnerships with other retailers that carry Caleres brands. Additionally, the company benefits from licensing agreements with other brands, expanding its reach in the footwear market. Seasonal promotions, effective marketing strategies, and a focus on customer engagement also contribute significantly to its earnings. The diverse brand portfolio allows Caleres to cater to different market segments, enhancing its revenue stability.

Caleres Financial Statement Overview

Summary

Caleres shows a mixed financial performance with strong gross and operating margins but faces challenges with declining revenue and free cash flow. The balance sheet is stable with manageable leverage, yet cash flow management needs improvement for long-term growth.

Income Statement

Caleres has shown a solid recovery in its income statement metrics. The Gross Profit Margin for TTM stands at approximately 44.5%, indicating effective cost management. However, the Net Profit Margin decreased to around 3.1% in TTM from 3.9% the previous year. Revenue has decreased by 3.2% over the last year, signaling a slight decline in sales momentum. The EBIT Margin is at 4.4% for TTM, highlighting stable operational efficiency despite the revenue dip. EBITDA Margin remains robust at 6.0% in TTM.

Balance Sheet

Caleres' balance sheet shows a reasonable leverage position with a Debt-to-Equity Ratio of approximately 1.41 in TTM, indicating reliance on borrowed funds but within a manageable range. The Return on Equity (ROE) for TTM is around 13.8%, showcasing decent profitability relative to equity. The Equity Ratio is moderate at 31.7% in TTM, suggesting a solid equity base to support its total assets.

Cash Flow

The cash flow analysis reflects some challenges, with Free Cash Flow decreasing significantly over the past year. The Free Cash Flow to Net Income Ratio is very low, indicating limited free cash generation relative to profits. However, the Operating Cash Flow to Net Income Ratio is approximately 0.75 in TTM, showing a decent conversion of net income into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.65B	2.72B	2.82B	2.97B	2.78B	2.12B
Gross Profit	1.17B	1.22B	1.26B	1.28B	1.23B	787.05M
EBITDA	129.08M	205.54M	253.94M	276.31M	257.08M	-432.19M
Net Income	59.75M	107.25M	163.87M	181.74M	137.02M	-438.99M
Balance Sheet
Total Assets	2.15B	1.89B	1.80B	1.84B	1.84B	1.87B
Cash, Cash Equivalents and Short-Term Investments	191.49M	29.64M	21.36M	33.70M	30.11M	88.30M
Total Debt	465.79M	826.55M	747.86M	887.63M	871.40M	1.12B
Total Liabilities	1.53B	1.29B	1.24B	1.41B	1.52B	1.66B
Stockholders Equity	613.30M	599.02M	560.63M	420.68M	318.57M	200.25M
Cash Flow
Free Cash Flow	-36.96M	55.41M	150.53M	61.84M	144.30M	104.29M
Operating Cash Flow	27.59M	104.56M	200.15M	125.88M	168.44M	126.35M
Investing Cash Flow	-63.45M	-51.69M	-49.62M	-64.04M	-24.14M	-22.06M
Financing Cash Flow	175.56M	-44.51M	-162.99M	-58.15M	-202.38M	-61.31M

Caleres Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 14.27
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CAL, the sentiment is Negative. The current price of 14.27 is below the 20-day moving average (MA) of 15.08, below the 50-day MA of 14.63, and below the 200-day MA of 16.62, indicating a bearish trend. The MACD of 0.04 indicates Positive momentum. The RSI at 43.73 is Neutral, neither overbought nor oversold. The STOCH value of 12.63 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CAL.

Caleres Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RCKY	77 Outperform	219.79M	11.70	4.90%	2.11%	-0.09%	24.18%
SHOO	74 Outperform	2.41B	25.19	11.02%	2.53%	7.80%	-48.10%
WWW	69 Neutral	2.36B	29.08	17.84%	1.37%	-2.83%	0.00%
CROX	68 Neutral	4.21B	20.71	16.64%	―	2.04%	-71.52%
WEYS	68 Neutral	291.43M	11.50	10.43%	10.02%	-6.39%	-14.72%
CAL	63 Neutral	$484.63M	8.22	9.50%	1.96%	-5.31%	-62.20%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%

Caleres Corporate Events

Caleres Completes Acquisition of Stuart Weitzman Brand

On August 4, 2025, Caleres, Inc. completed the acquisition of the Stuart Weitzman brand from Tapestry, Inc. for a net purchase price of $108.7 million, excluding cash received at closing. This acquisition, initially announced in February 2025, is expected to enhance Caleres’ portfolio and strengthen its position in the footwear industry.

The most recent analyst rating on (CAL) stock is a Hold with a $45.00 price target. To see the full list of analyst forecasts on Caleres stock, see the CAL Stock Forecast page.